Published in:
01-06-2021 | Obesity | Sleep Breathing Physiology and Disorders • Short Communication
Long-term effectiveness of CPAP in patients with severe obesity-hypoventilation syndrome
Authors:
Luis Pérez de Llano, Olalla Castro-Añón, Laura Castro-Cabana, Lidia Méndez Marote, Rafael Golpe
Published in:
Sleep and Breathing
|
Issue 2/2021
Login to get access
Abstract
Purpose
The optimal mode of long-term positive airway pressure (PAP) treatment for obesity-hypoventilation syndrome (OHS) is not clear. The objectives of this study were to analyze whether or not patients with severe OHS treated with continuous positive airway pressure (CPAP) remained controlled with this therapy over the long term and to investigate which variables were associated with CPAP failure and the need to switch to non-invasive ventilation (NIV).
Methods
In a retrospective single-center study, patients admitted to the hospital because of severe OHS between 1996 and 2015 were analyzed. A multiple regression analysis was performed in order to determine which variables were associated with either CPAP success or failure to maintain long-term control.
Results
Of 126 consecutive patients, 115 accepted long-term PAP treatment. CPAP or NIV treatment was prescribed according to a protocol that included overnight polysomnographic PAP titration. Follow-up time was 8.0 ± 4.8 years. At the end of this period, 29% of CPAP-treated patients had been re-assigned to NIV because of recurrence of global respiratory failure. High levels of obesity, weight gain, lower FEV1/FVC values and the need for nocturnal supplementary oxygen independently predicted CPAP failure.
Conclusion
CPAP therapy for severe OHS in patients who have these risk factors should be closely monitored in the long-term for possible treatment failure.